Cross-trait genomic and proteomic analyses identify shared risk loci and candidate therapeutic targets for type 2 diabetes and coronary artery disease
Gene Reports · 2026-11 · 102688
DOI: 10.1016/j.genrep.2026.102688 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene Reports, 2026-11. Verfasst von Xuan Sun und 5 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes (T2D) and coronary artery disease (CAD) frequently coexist, yet their shared genetic basis and molecular mechanisms remain poorly understood.
Methods
We integrated cross-trait genomic analyses, transcriptomics, proteomics, and cell-type-stratified analyses to systematically characterize the shared genetic architecture of T2D and CAD, and to prioritize potential therapeutic targets and relevant cellular contexts.
Results
T2D and CAD exhibited significant positive genetic correlations at both the genome-wide and local levels (rg = 0.3697 and 0.272, all P < 0.05). MiXeR analysis indicated that the two diseases shared 3,052 trait-influencing variants, with a genetic correlation coefficient of 0.400. Stratified linkage disequilibrium score regression (S-LDSC) revealed that the heritability of both diseases was significantly enriched in active regulatory regions, including H3K27ac-marked enhancers and super-enhancers. Cross-trait analysis identified two shared susceptibility loci, rs2972146 and rs7903146. Further integration of transcriptome-wide association study (TWAS), multi-tissue TWAS, protein quantitative trait locus (pQTL) analysis, and Mendelian randomization (MR) analysis prioritized GCKR, HSF1, and QPCTL as three potential therapeutic targets. Mediation analysis further showed that T2D mediated 22.6% and 14.0% of the effects of HSF1 and QPCTL on CAD, respectively. Cell-type-specific MR suggested that oligodendrocyte precursor cells (OPCs) may represent a key cellular context (OR = 1.18, 95% CI 1.04–1.33, P = 0.0093).
Conclusion
Our study reveals a shared genetic basis between T2D and CAD and further refines cross-trait genetic signals to three candidate targets, GCKR, HSF1, and QPCTL. These findings suggest that OPCs may contribute to this comorbid process and provide a basis for mechanistic dissection and precision intervention in cardiometabolic comorbidity.
Zitieren
APA
Sun, X., Xu, Y., Wang, J., Zhang, Z., Hou, C., & Li, Q. (2026). Cross-trait genomic and proteomic analyses identify shared risk loci and candidate therapeutic targets for type 2 diabetes and coronary artery disease. Gene Reports, 102688. https://doi.org/10.1016/j.genrep.2026.102688
Vancouver
Sun X, Xu Y, Wang J, Zhang Z, Hou C, Li Q. Cross-trait genomic and proteomic analyses identify shared risk loci and candidate therapeutic targets for type 2 diabetes and coronary artery disease. Gene Reports. 2026:102688. doi:10.1016/j.genrep.2026.102688
BibTeX
@article{Sun2026,
author = {Sun, Xuan and Xu, Yifeng and Wang, Jie and Zhang, Zeming and Hou, Chengzhi and Li, Qiyang},
title = {Cross-trait genomic and proteomic analyses identify shared risk loci and candidate therapeutic targets for type 2 diabetes and coronary artery disease},
journal = {Gene Reports},
year = {2026},
pages = {102688},
doi = {10.1016/j.genrep.2026.102688}
}
EUVIMED